Treatment with CNM-Au8 led to clinical improvements in relapsing-remitting MS patients that linked to signs of nerve cell ...

The Phase 4 ENABLE study is set to be first in the U.S. to collect real-world safety and efficacy data of Briumvi for ...

Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.

A new artificial intelligence (AI) tool called MindGlide was found to accurately calculate MS-related brain damage using a ...

Non-drug therapy costs for people with MS in Austria can be high, averaging €136 per month, according to a study.

Getting used to living with MS is like trying to cook in a kitchen that's unfamiliar, columnist Ben Hofmeister writes.

The researchers suggest clinicians might tailor their approach to account for Asian Americans' younger average age when they ...

No added benefits in slowing MS disability progression were found in a study that increased Ocrevus dosing to 2-3 times the ...

MS Canada is calling on everyone across Canada to join one of the many MS Bike rides to help raise funds for multiple ...

Pain is challenging, but it doesn't have to define your life. Episode 2 of Get Tough on Multiple Sclerosis offers practical ...

A small molecule that blocks TYK2 in the brain showed promise for reducing disease activity in mouse models of multiple ...

Quantum is partnering with Massachusetts General Hospital on a clinical study to test a PET tracer for monitoring response to ...